Where ANI Pharmaceuticals Stands With Analysts
Portfolio Pulse from Benzinga Insights
ANI Pharmaceuticals (NASDAQ:ANIP) has received positive analyst ratings in the last quarter, with 4 bullish and 1 somewhat bullish ratings. The company's average price target has increased by 8.53% from the previous average price target of $51.60 to $56.0.
July 21, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ANI Pharmaceuticals has received positive analyst ratings, which could boost investor confidence and potentially drive the stock price up.
Analyst ratings often influence investor sentiment. The positive ratings for ANI Pharmaceuticals indicate a bullish outlook, which could lead to increased demand for the stock and potentially drive the price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100